About Clora

We’re building the future of flexible work in life sciences—connecting biotech companies with specialized consultants so critical programs never stall waiting for the “perfect” hire.

Backed By Leaders in Technology, Life Sciences, and Marketplace Innovation

What We Do

Clora is a curated talent marketplace connecting biotech and pharmaceutical companies with 15,000+ specialized life sciences consultants that span the drug development lifecycle.

Rigorous vetting

Clora is a curated talent marketplace connecting biotech and pharmaceutical companies with 15,000+ specialized life sciences consultants that span the drug development lifecycle.

Curated matching

We present 2-5 high-fit candidates, not stacks of resumes. Companies interview finalists and make decisions in days, not weeks.

Full-service support

We handle the operational overhead: contracting, compliance, invoicing, payments, and year-end tax documents. You focus on the science. We handle the infrastructure.

THE RESULT

Companies fill critical gaps fast, preserve capital, and maintain sponsor-side control—without overbuilding permanent headcount or fully outsourcing ownership to a CRO. Consultants get high-quality projects without constant business development.

Founded in 2016 by biotech professionals who experienced the rigidity and pain of full-time hiring and inefficient CRO relationships firsthand, Clora was built to be faster than full-time recruiting, more flexible than CROs, and more specialized than general talent platforms. We’ve facilitated thousands of engagements across hundreds of preclinical stage startups to commercial-ready companies, with an average project value of $100K, 4.8 out of 5 consultant satisfaction rating, and a 60% extension rate.

Our Purpose

Building Resilient Teams in an Uncertain Industry

Industry Reality - Biotech is fundamentally different from other industries. Nine out of ten drug candidates fail. Clinical timelines shift based on data. Strategic priorities change. Capital markets fluctuate.

The Hiring Problem - In this environment of constant uncertainty, the traditional hiring playbook— build a large full-time team and hope the program succeeds—creates organizational fragility. Companies overhire during fundraising, then face painful layoffs when trials fail or funding tightens. This cycle burns capital, damages morale, and forces teams to lose talented people they may need again in six months.

The CRO Alternatives - The alternative—outsourcing everything to CROs—solves the flexibility problem but introduces new risks: loss of institutional knowledge, reduced control over critical decisions, and misaligned incentives.

The Clora Model

Clora was built on a different model: resilient teams that can scale with program needs without creating fragility.

The most effective biotech organizations combine three layers

This approach enables companies to move faster than competitors constrained by 4-6 month hiring timelines, preserve capital by avoiding premature team expansion, and maintain control over critical decisions—while building organizational resilience that survives program pivots and market cycles.

We don’t just connect companies with consultants. We enable biotech teams to operate with the speed and flexibility that drug development demands and that patients deserve — without sacrificing scientific rigor or strategic control. Every delay we help avoid is a step closer to patients receiving the therapies they need.

Leadership

Rahul Chaturvedi, Founder and CEO

Rahul founded Clora in 2016 after leading clinical development teams at biotech and medical device companies, resulting in bringing six new therapies to patients.

His experience spans IND-enabling studies through commercial approval across rare diseases, ophthalmology, allergy & immunology, and metabolic disorders. He experienced firsthand the fragility of traditional biotech staffing: companies overhiring during fundraising, then laying off talented people when programs failed or timelines shifted. Meanwhile, the best expertise often sat on the sidelines as independent consultants, inaccessible because companies lacked efficient ways to find and engage them.

Clora was born from the conviction that biotech teams could be built differently—with the speed and flexibility that drug development demands, without the organizational fragility that comes from betting everything on permanent headcount.

What started as a network of 50 consultants has grown to 15,000+, supporting thousands of projects across hundreds of companies from pre-IND startups to commercial-stage leaders.

Outside of Clora, Rahul hosts the Biotech2050 podcast, exploring the future of leadership, drug development, and innovation in life sciences.

Contact Us

We’d love to hear from you.

Have questions? Interested in careers at Clora?

Use the form to get in touch — just indicate your area of interest.